Patents by Inventor Matthias Eikermann

Matthias Eikermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acyclic cucurbit[n]uril type molecular containers to treat intoxication and decrease relapse rate in substance abuse disorders
    Patent number: 9956229
    Abstract: Provided are methods for reversing the effects of drugs of abuse. The method involves administering acyclic CB[n]-type compounds to a mammal in need of the reversal of the effects from a drug of abuse.
    Type: Grant
    Filed: October 19, 2015
    Date of Patent: May 1, 2018
    Assignees: University of Maryland, College Park, General Hospital Corporation
    Inventors: Lyle David Isaacs, Matthias Eikermann, Cristina Cusin, Joseph Cotten
  • ACYCLIC CUCURBIT[N]URIL TYPE MOLECULAR CONTAINERS TO TREAT INTOXICATION AND DECREASE RELAPSE RATE IN SUBSTANCE ABUSE DISORDERS
    Publication number: 20170246180
    Abstract: Provided are methods for reversing the effects of drugs of abuse. The method involves administering acyclic CB[n]-type compounds to a mammal in need of the reversal of the effects from a drug of abuse.
    Type: Application
    Filed: October 19, 2015
    Publication date: August 31, 2017
    Inventors: Lyle David Isaacs, Matthias Eikermann, Cristina Cusin, Joseph Cotten
  • Reversal of drug-induced neuromuscular block using novel molecular containers
    Patent number: 9469648
    Abstract: Provided are methods for reversing the effects of agents used for muscular immobilization and/or loss of consciousness and/or loss of pain perception. The method comprises administering a composition comprising acyclic CB[n]-type compounds to an individual in need of reversal of the effects of neuromuscular blocking agents and/or anesthetic agents such that the effects of the agent(s) are partially fully reversed.
    Type: Grant
    Filed: October 13, 2011
    Date of Patent: October 18, 2016
    Assignees: University of Maryland, College Park, General Hospital Corporation
    Inventors: Lyle David Isaacs, Da Ma, Matthias Eikermann
  • REVERSAL OF DRUG-INDUCED NEUROMUSCULAR BLOCK USING NOVEL MOLECULAR CONTAINERS
    Publication number: 20130345273
    Abstract: Provided are methods for reversing the effects of agents used for muscular immobilization and/or loss of consciousness and/or loss of pain perception. The method comprises administering a composition comprising acyclic CB[n]-type compounds to an individual in need of reversal of the effects of neuromuscular blocking agents and/or anesthetic agents such that the effects of the agent(s) are partially fully reversed.
    Type: Application
    Filed: October 13, 2011
    Publication date: December 26, 2013
    Applicants: GENERAL HOSPITAL CORPORATION, UNIVERSITY OF MARYLAND, COLLEGE PARK
    Inventors: Lyle David Isaacs, Da Ma, Matthias Eikermann